Abbott opens new formulation plant in HQ

US health care major Abbott has opened a new $53.0 million formulation development center at its headquarters in Abbott Park, Illinois. The plant provides capabilities for the formulation of new investigational medicines that have the potential to treat deadly diseases.

The two-story, 64,000-square-foot facility, which features a flexible design with modular walls and ceilings that will allow for rapid future expansion, is currently developing capsule and tablet formulations for clinical studies involving new compounds to treat cancer, hepatitis, pain and other areas. Completed at the start of the year, the working facility houses 17 dedicated onsite employees, with more than 40 additional staff regularly working there.

The firm believes the center's technology and equipment will allow it to expedite its development programs, potentially bringing innovative new pharmaceuticals to patients faster.